Rachel Steinmetz

Postdoctoral Fellow

Supervised by Martin Felices

Rachel’s research aims to enhance NK cell anti-tumor activity in the solid tumor microenvironment of lung cancer and mesothelioma using novel engineered tri-specific killer engagers (TriKE) and TriKE Poly-Antigen Cytokine-receptor Complex (PACC) preclinical therapeutics.